Gene · 4928
Papers2,783
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,783
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nuclear transport protein suppresses Tau neurodegeneration. | Adv Protein Chem Struct Biol | 2025 | 39843141 | PubTator, text mining | PubMed |
| Clinicopathologic and Molecular Characterization of NUP98-Rearranged Acute Leukemias. | Int J Lab Hematol | 2025 | 39836982 | PubTator, text mining | PubMed |
| Precision medicine for high-risk gene fusions in pediatric AML: a focus on KMT2A, NUP98, and GLIS2 rearrangements. | Blood | 2025 | 39808803 | PubTator, text mining | PubMed |
| Met58 and di-acidic motif located at C-terminal region of SARS-CoV-2 ORF6 plays a crucial role in its structural conformations. | Biophys Chem | 2025 | 39724814 | PubTator, text mining | PubMed |
| Landscape of somatic mutations and clonal evolution in NUP98-rearranged adult acute myeloid leukaemia. | Br J Haematol | 2025 | 39701595 | PubTator, text mining | PubMed |
| Progressive chromatin rewiring by ETO2::GLIS2 revealed in a genome-edited human iPSC model of pediatric leukemia initiation. | Blood | 2025 | 39656971 | PubTator, text mining | PubMed |
| Protein-Specific Crowding Accelerates Aging in Protein Condensates. | Biomacromolecules | 2025 | 39648588 | PubTator, text mining | PubMed |
| Complete remission of NUP98 fusion-positive acute myeloid leukemia with the covalent menin inhibitor BMF-219, icovamenib. | Haematologica | 2025 | 39633542 | PubTator, text mining | PubMed |
| Diagnosis of invasive encapsulated follicular variant papillary thyroid carcinoma by protein-based machine learning. | J Pathol Transl Med | 2025 | 39440350 | PubTator, text mining | PubMed |
| Rare Non-Cryptic NUP98 Rearrangements Associated With Myeloid Neoplasms and Their Poor Prognostic Impact. | Ann Lab Med | 2025 | 39344146 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| Solid-state NMR studies of proteins in condensed phases. | Magn Reson Lett | 2024 | 40919591 | PubTator, text mining | PubMed |
| Phase-separated chromatin compartments: Orchestrating gene expression through condensation. | Cell Insight | 2024 | 39512706 | PubTator, text mining | PubMed |
| Selective degradation of multimeric proteins by TRIM21-based molecular glue and PROTAC degraders. | Cell | 2024 | 39488207 | PubTator, text mining | PubMed |
| NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression in AML. | Cell Rep | 2024 | 39475509 | PubTator, text mining | PubMed |
| NanoPlex: a universal strategy for fluorescence microscopy multiplexing using nanobodies with erasable signals. | Nat Commun | 2024 | 39384781 | PubTator, text mining | PubMed |
| Prognostic importance of NUP98-rearrangements in acute myeloid leukemia: A systematic review and meta-analysis. | Caspian J Intern Med | 2024 | 39359452 | PubTator, text mining | PubMed |
| NUP98 oncofusions in myeloid malignancies: An update on molecular mechanisms and therapeutic opportunities. | Hemasphere | 2024 | 39323480 | PubTator, text mining | PubMed |
| Case report: Successful therapy with azacitidine for acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia. | Front Oncol | 2024 | 39296977 | PubTator, text mining | PubMed |
| Distinct FLT3 Pathways Gene Expression Profiles in Pediatric De Novo Acute Lymphoblastic and Myeloid Leukemia with FLT3 Mutations: Implications for Targeted Therapy. | Int J Mol Sci | 2024 | 39273530 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4928/papers?page=8